MALAT1 and non-small cell lung carcinoma: METTL3 could promote m6A modification and translation of YAP mRNA through recruiting YTHDF1/3 and eIF3b and increased mRNA stability of YAP via the MALAT1-miR-1914-3p-YAP axis, thereby inducing cisplatin resistance in NSCLC [44].